Syllable, an AI-powered patient engagement platform, raised $28 million in a Series B funding round. Oak HC/FT led the round with participation from previous investor Section 32. The company plans to utilize the funding to scale partnerships with health systems, deploy with payers, and grow the team.
According to the company, it has developed an AI platform that answers every call received by a hospital and enables automated workflows and self-service options to help patients find and take the correct next step in their healthcare journey. The platform introduces patients to an agent for situations that require a human touch for successful call resolution.
In March 2020, Syllable launched a COVID-19 assistant, the first AI assistant available to help health systems deploy automated solutions to address the sudden surge in patient inquiries related to the pandemic. Subsequently, it has expanded to support vaccine distribution, including outbound voice and SMS campaigns.
“Syllable has been building an enterprise assistant that modernizes the healthcare contact center and improves the patient experience to be more convenient, reliable, and empathetic. This funding marks a major milestone that will accelerate our progress towards realizing this vision,” said Kobus Jooste, CEO of Syllable.
Vig Chandramouli, Principal at Oak HC/FT, joins the Syllable Board of Directors commented: “Customer experience in healthcare lags behind almost every other industry, and Syllable is leveraging technology to solve that. We’re proud to back a company that shares our vision for customer-first healthcare, and we’re excited to partner with the team at Syllable to drive improved access to information and care for patients”.
Digital health companies raised $7.2 billion in Q1 2021, according to Mercom’s Q1 2021 Digital Health Funding and M&A Report.
